Early treatment with infliximab for Crohn's disease patients

被引：0
|
作者：
de Chambrun, G. Pineton [1 ]
Libier, L. [2 ]
Nachury, M. [2 ]
Collins, M. [3 ]
Koriche, D. [4 ]
Gower-Rousseau, C. [5 ]
Zerbib, P. [4 ]
Cortot, A. [6 ]
Colombel, J. -F. [7 ]
Desreumaux, P. [2 ]
机构：
[1] Univ Montpellier I, Gastroenterol & Hepatol, Montpellier, France
[2] CHU Lille, Dept Gastroenterol, Lille, France
[3] APHP Paris Sud Univ, Gastroenterol, Le Kremlin Bicetre, France
[4] Lille Univ Hosp, Dept Colorectal Surg, Lille, France
[5] North France Univ, Lille Univ Hosp, Epidemiol, Lille, France
[6] North France Univ, Lille Univ Hosp, Gastroenterol, Lille, France
[7] Mt Sinai Hosp, Gastroenterol, New York, NY 10029 USA
来源：
JOURNAL OF CROHNS & COLITIS | 2015年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P346
引用
收藏
页码：S251 / S252
页数：2
相关论文
共 50 条
  • [21] Comparison of Techniques for Monitoring Infliximab and Antibodies to Infliximab in Crohn's Disease Patients with Infliximab Treatment Failure
    Steenholdt, Casper
    Brynskov, Jorn
    Thomsen, Ole
    Munck, Lars
    Fallingborg, Jan
    Christensen, Lisbet
    Pedersen, Gitte
    Kjeldsen, Jens
    Bendtzen, Klaus
    Lockton, Steven
    Hauenstein, Scott
    Shringarpure, Reshma
    Chuang, Emil
    Singh, Sharat
    Ainsworth, Mark
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S622 - S622
  • [22] An Audit of the Reasons for Discontinuation of Infliximab Treatment in Patients with Crohn's Disease
    Krupa, Lukasz Z.
    Jamieson, Crawford P.
    Kennedy, Hugh J.
    Hart, Andrew
    Fisher, Nicola
    GASTROENTEROLOGY, 2009, 136 (05) : A204 - A204
  • [23] Consistent treatment benefit with infliximab in patients with fistulizing Crohn's disease
    Onken, JE
    Sands, B
    Hogezand, R
    Haens, G
    Braakman, T
    DeWoody, K
    Schaible, T
    Targon, S
    Hanauer, S
    van Deventer, S
    Rutgeerts, P
    Present, D
    GASTROENTEROLOGY, 1999, 116 (04) : A788 - A788
  • [24] Infliximab is not an effective treatment in patients with Crohn's disease and internal fistulae
    Kouklakis, G
    Moschos, J
    Mpoumponaris, A
    Kadis, S
    Minopoulos, G
    GUT, 2005, 54 : A91 - A92
  • [25] Infliximab in the treatment of patients with Crohn's disease. Preliminary report
    Gellona, Jose, V
    Zarraonandia A, Anton
    Zuniga D, Alvaro
    Palma C, Renato
    Contreras P, Jaime
    Silva Ch, Jaime
    Gonzalez D, Robinson
    Quintana, Carlos, V
    REVISTA MEDICA DE CHILE, 2006, 134 (03) : 320 - 325
  • [26] Avoiding infliximab in the treatment of Crohn's disease in patients with multiple sclerosis
    Nanavati, SA
    Ergun, GA
    Schwartz, JT
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (10): : 2333 - 2334
  • [27] Desensitisation to infliximab in patients with Crohn's disease
    Lelong, J
    Duburque, C
    Fournier, C
    Colombel, JF
    Desreumaux, P
    Tonnel, AB
    Wallaert, B
    REVUE DES MALADIES RESPIRATOIRES, 2005, 22 (02) : 239 - 246
  • [28] Early Failure of Infliximab in Patients with Ulcerative Colitis as Compared to Patients with Crohn's Disease
    Shah, Rushikesh
    Herrera, Henry
    Swaroop, Prabhakar
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S507 - S507
  • [29] Risks and benefits of infliximab for the treatment of Crohn's disease
    Siegel, Corey A.
    Hur, Chin
    Korzenik, Joshua R.
    Sands, Bruce E.
    GASTROENTEROLOGY, 2006, 130 (04) : A71 - A72
  • [30] Recent Trends of Infliximab Treatment for Crohn's Disease
    Kim, Mi Jin
    Choe, Yon Ho
    PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION, 2012, 15 (01) : 19 - 22
12345